You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Express Scripts
Harvard Business School
Boehringer Ingelheim
McKinsey
Dow
Baxter

Last Updated: April 9, 2020

DrugPatentWatch Database Preview

FLUDEOXYGLUCOSE F18 Drug Profile


Email this page to a colleague

» See Plans and Pricing

« Back to Dashboard

When do Fludeoxyglucose F18 patents expire, and when can generic versions of Fludeoxyglucose F18 launch?

Fludeoxyglucose F18 is a drug marketed by Downstate Clincl, 3d Imaging Drug, Biomedcl Res Fdn, Brigham Womens, Cardinal Health 414, Childrens Hosp Mi, Cpdc, Decatur, Essential Isotopes, Feinstein, Hot Shots Nm Llc, Jubilant Draximage, Kettering Medctr, Kreitchman Pet Ctr, Lantheus Medical, Ma General Hosp, Mcprf, Mem Sloan-kettering, Methodist Hosp Res, Midwest Medcl, Mips Crf, Ncm Usa Bronx Llc, Northland, Petnet, Precision Nuclear, Queen Hamamatsu Pet, Shertech Labs Llc, Sofie, Spectron Mrc Llc, Trustees Univ Pa, Ucla Biomedical, Ucsf Rodiopharm, Uihc Pet Imaging, Univ Michigan, Univ Tx Md Anderson, Univ Tx Sw Medctr, Univ Utah Cyclotron, Weill Medcl Coll, Wi Medcl Cyclotron, and Wusm Cyclotron. and is included in forty-two NDAs.

The generic ingredient in FLUDEOXYGLUCOSE F18 is fludeoxyglucose f-18. There are eight drug master file entries for this compound. Thirty-six suppliers are listed for this compound. Additional details are available on the fludeoxyglucose f-18 profile page.

Summary for FLUDEOXYGLUCOSE F18
Drug patent expirations by year for FLUDEOXYGLUCOSE F18
Recent Clinical Trials for FLUDEOXYGLUCOSE F18

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
CHU de Quebec-Universite LavalPhase 2
ECOG-ACRIN Cancer Research GroupPhase 3
Canary FoundationPhase 2

See all FLUDEOXYGLUCOSE F18 clinical trials

Pharmacology for FLUDEOXYGLUCOSE F18
Synonyms for FLUDEOXYGLUCOSE F18
(18)FDG
[18F]FDG
[F-18]-FDG
105851-17-0
18-FDG
18DG
18FDG
2-(fluoro-(18)F)-2-deoxy-alpha-glucopyranose
2-(Fluoro-18F)-2-deoxy-alpha-glucopyranose
2-deoxy-2-((18)F)fluoro-alpha-D-glucopyranose
2-deoxy-2-((18)F)fluoro-alpha-D-glucose
2-deoxy-2-(fluoro-(18)F)-alpha-D-glucopyranose
2-Deoxy-2-(fluoro-18f)-a-D-glucopyranose
2-Deoxy-2-fluoro-(sup 18)F-alpha-D-glucopyranose
851D170
AKOS006272016
alpha-D-Glucopyranose, 2-deoxy-2-(fluoro-(sup 18)F)-
alpha-D-Glucopyranose, 2-deoxy-2-(fluoro-18F)-
CHEBI:31617
CHEMBL1092067
D01843
DTXSID50894178
F-18 FDG
Flucis
Fludeoxyglucose ((sup 18)F)
Fludeoxyglucose (18F)
Fludeoxyglucose (18F) (JAN/INN)
Fludeoxyglucose F 18
Fludeoxyglucose F 18 (TN)
Fludeoxyglucose F 18 (USP)
Fludeoxyglucose f 18 [USAN:USP]
FLUDEOXYGLUCOSE F-18
Fludeoxyglucose f(sup 18)
FLUORINE F 18 FLUORODEOXYGLUCOSE
Fluorodeoxyglucose F 18
MOLI000964
Q419849
S8FDG
SBT3GBX27W
SCHEMBL135994
UNII-SBT3GBX27W
ZCXUVYAZINUVJD-AHXZWLDOSA-N

US Patents and Regulatory Information for FLUDEOXYGLUCOSE F18

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Univ Tx Sw Medctr FLUDEOXYGLUCOSE F18 fludeoxyglucose f-18 INJECTABLE;INTRAVENOUS 210265-001 Feb 6, 2020 AP RX No No   Start Trial   Start Trial   Start Trial
Sofie FLUDEOXYGLUCOSE F18 fludeoxyglucose f-18 INJECTABLE;INTRAVENOUS 203665-001 Feb 14, 2013 AP RX No Yes   Start Trial   Start Trial   Start Trial
Wusm Cyclotron FLUDEOXYGLUCOSE F18 fludeoxyglucose f-18 INJECTABLE;INTRAVENOUS 203935-001 Feb 5, 2014 AP RX No No   Start Trial   Start Trial   Start Trial
Precision Nuclear FLUDEOXYGLUCOSE F18 fludeoxyglucose f-18 INJECTABLE;INTRAVENOUS 204546-001 Apr 7, 2015 RX No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Harvard Business School
Boehringer Ingelheim
McKinsey
Dow
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.